Notice to contributors of Mycology Today
The editorial board welcomes manuscripts consistent
with aims and scope of the series.
Submission of an article is understood to imply that
the article is original and unpublished and not being considered
for publication elsewhere. The responsible author must ensure that
the article has been seen and approved by all the other authors.
Papers accepted for publication become the copyright of the series
and will not be returned. The articles published in the series
are protected by copyright, which covers translation rights and
the exclusive right to reproduce and distribute all the articles
printed in the series. All articles will be subject to peer-review
by one or more referees and authors are invited to propose 3 potential
reviewers in their submission letter.
Publication charge is not applied for articles originating
from CIS states, or if the corresponding author subscribes to the
series. The Editorial Board of «Mycology Today»
assumes no responsibilities for the statements made by its contributors.
Manuscript submission guidelines
Submitted manuscripts should conform with the «Uniform
requirements for manuscripts submitted to biomedical seriess».
(Ann Intern Med 1997;126:36-47.)
Submission. Manuscripts should be submitted together
with official submission letter, signatures, contact postal and
E-mail addresses of one or more authors. The articles should be
written in correct scientific Russian or English. Manuscripts should
be sent on a newly formatted 3,5 inch floppy disks. 2 printed one-side
only double-spaced copies containing figures and tables and signed
by authors should accompany the disk. Articles may be submitted
File requirements. Submitted files are accepted
only in RTF format or MS Word v. 6.0 and above. Larger files (>
1 Mb) may be compressed only with *.zip or *.rar compression. Editors
may request figurefiles.
Text formatting. Text of the manuscript should
be placed on A4 (210 x 297 mm) format with all margins set at 25
mm. Use only standard font Times New Roman, size12, double spaced.
Organisation of the manuscript. Article text should
be accompanied by full and brief titles, authors full names, complete
names and postal addresses of the affiliation(s), originating city
and country. Provide abstract not exceeding 150 words with no abbreviations,
and at least 5 keywords. Standard manuscripts should be organised
as follows: title page, abstract, introduction, materials and methods,
results, discussion, conclusion, acknowledgments, references, tables,
legends for figures. Materials and methods should clearly and concisely
describe all compounds and methods used. A brief note on the statistical
methods used to evaluate the results should also be included. The
review articles should contain sections with subheadings. Abbreviations
should be used sparingly and always given in full at the first mention.
All measurements should be in metric units. All figures and diagrams
should be accompanied by a legend and have Arabic numbers. Low resolution
photographic figures are not allowed. Digital images is preferred.
Indicate magnification when applicable.
References. Reference list should be composed
with abbreviations according to Index Medicus style. Number references
consecutively as they appear in text. List all authors when 6 or
less, otherwise list first 3 and add “et al”. Examples of correct
form of references are given below:
1. Mosmann TR, Coffman RL. Heterogeneity of cytokine
secretion patterns and functions of helper T cells. Adv Immunol
2. Janeway CA, Travers P, Walport M, Shlomchik
M. Immunobiology: The Immune System in Health and Disease. 5 ed.
Garland Science, 2001.
3. Sergeev AY, Sundukova IO, Lysenko VI et al.
[Current approach to the treatment of onychomycosis]. Voen Med
Zh 2002; 323 (12):38-41.
Authors are responsible for recognising and disclosing
financial and other conflicts of interest that may bias their work.
When reporting experiments on human subjects, indicate
whether the procedures followed were in accordance with the ethical
standards of the responsible committee on human experimentation
(institutional or regional) or with the Helsinki Declaration of
1975, as amended in 1983.